Supply Chain

  1. Inventory Management, Staff Training, And Timeline Optimization 11/13/2023

    In this segment, Umoja's Co-Founder and CTO Ryan Crisman and BMS’ Global Head, Cell Therapy Logistics and Shipping Systems, Rookie Gleich explain the improvements that can be made in each of the following: inventory management, staff training, and timeline.

  2. An Inside Look At Umoja Biopharma And Bristol Myers Squibb's Cold Chains 11/13/2023

    Umoja's Co-Founder and CTO Ryan Crisman details The CLIMB and how an optimized cold chain is critical in the work being done there. Rookie Gleich, Global Head, Cell Therapy Logistics and Shipping Systems, BMS explains some of the cell therapy temperature standardization and why a wider temperature range may optimize the process.

  3. mRNA For Cancer Immunotherapy 2024 Outlook | Audience Q&A 1/29/2024

    During our Cell & Gene Live, mRNA For Cancer Immunotherapy 2024 Outlook, our expert panelists answered audience questions regarding patient safety, foreseeable challenges in mRNA cancer immunotherapy for solid tumors, and much more.

  4. Biopharma Supply, Reimagined: Blarney, A Climate-Neutral Facility For Best-In-Class Filters 11/11/2025

    Explore how a new, climate-neutral manufacturing facility strengthens biopharma supply chains. Understand the benefits of its advanced filtration technologies and commitment to environmental sustainability.

  5. Regulatory Considerations For An Optimized Cold Chain 11/13/2023

    Here, Umoja's Co-Founder and CTO Ryan Crisman and BMS’ Global Head, Cell Therapy Logistics and Shipping Systems, Rookie Gleich detail some of the cold chain for cell therapies is beholden to regulatory requirements.

  6. Comparing Manual Vs. Automated Processing And Thawing Systems 4/15/2025

    In this segment of our Cell & Gene Live, Optimizing Storage Solutions for iPSCs, expert panelists Pratik Jaluria, Ph.D., SVP Technical Development Strategy at BlueRock Therapeutics, Bruno Marques, Ph.D. VP, Process and Product Development at Century Therapeutics, and Kate Rochlin, Ph.D., COO at IN8bio share that a well-constructed manual operation can be matched by an automated system, but there is a higher capital expenditure.

  7. Thermo Fisher Scientific Single-Use Global Manufacturing Network 4/18/2022

    We have implemented a multi-tier strategy to improve the resiliency of our supply chain and created the largest networked single-use manufacturing organization in the world.

  8. Balancing Innovation With Manufacturability When GMP-Grade Is Unavailable 12/4/2025

    Some raw materials simply aren't available in GMP. Experts Yan Zhi and Lawrence Thompson describe risk assessment approaches that inform sourcing decisions in this segment from Cell & Gene Live "Viability On The Line." Some investigational therapies require many unique raw materials, and controlling them appropriately gets tricky. Complexities also vary by modality and batch size. Control strategies must be adaptable.

  9. Optimizing Your Cold Chain For Cell Therapies | Audience Questions 11/13/2023

    In this segment, Umoja's Co-Founder and CTO Ryan Crisman and BMS’ Global Head, Cell Therapy Logistics and Shipping Systems, Rookie Gleich answer questions from the audience, including the best way to de-risk contract couriers' use of contract carriers for specialty shipments and more.

  10. Bridging The Gap Between Lab Development And GMP Manufacturing 4/15/2025

    In this first segment of Cell & Gene Live, Optimizing Storage Solutions for iPSCs, expert panelists Pratik Jaluria, Ph.D., SVP Technical Development Strategy at BlueRock Therapeutics, Bruno Marques, Ph.D. VP, Process and Product Development at Century Therapeutics, and Kate Rochlin, Ph.D., COO at IN8bio focus on best practices for translating laboratory development processes into CGMP manufacturing settings.